Back to top

medical: Archive

Derek Lewis

These 3 Buy-Rated Stocks Have Been Red-Hot

While February is generally known to be a bit cold, these three stocks have been red-hot, rewarding investors considerably following strong quarterly results.

PEGANegative Net Change APPNegative Net Change MEDPNegative Net Change

Mark Vickery

Top Research Reports for NVIDIA, Visa & Amgen

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen Inc. (AMGN).

VPositive Net Change EMRNegative Net Change AMGNNegative Net Change CBNegative Net Change NVDANegative Net Change PCARPositive Net Change

Zacks Equity Research

Viatris' (VTRS) Q4 Earnings and Revenues Miss Estimates

Viatris (VTRS) reports lower-than-expected fourth-quarter financial results, as both earnings and sales miss estimates. Stock declines in pre-market.

ACETNegative Net Change PBYIPositive Net Change ADMANegative Net Change VTRSNegative Net Change

Zacks Equity Research

Philips' (PHG) New Innovation to Boost Neurovascular Diagnosis

Philips (PHG) announces its latest Azurion neuro biplane system, which aims to improve the diagnosis of stroke and major neurovascular diseases. The system is designed for superior patient care.

PHGNegative Net Change CAHPositive Net Change CORNegative Net Change ELVNegative Net Change

Zacks Equity Research

Patterson Companies (PDCO) Misses on Q3 Earnings, Lowers EPS View

Patterson Companies' (PDCO) third-quarter fiscal 2024 results reflect an improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales appear weak.

CAHPositive Net Change PDCONegative Net Change CORNegative Net Change ELVNegative Net Change

Zacks Equity Research

Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves

Inogen's (INGN) fourth-quarter earnings and revenues miss their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.

CAHPositive Net Change CORNegative Net Change INGNNegative Net Change ELVNegative Net Change

Zacks Equity Research

Acadia Healthcare (ACHC) Q4 Earnings Beat on Strong Admissions

Acadia Healthcare's (ACHC) Q4 results gain on strong growth in revenue per patient day. It expects adjusted EPS of $3.40-$3.70 for 2024, the mid-point of which implies a 3.2% rise from the 2023 reported figure.

SEMNegative Net Change ACHCNegative Net Change LNTHNegative Net Change EHCNegative Net Change

Zacks Equity Research

Universal Health (UHS) Q4 Earnings Beat on Adjusted Admissions

Universal Health (UHS) expects net revenues between $15.411 billion and $15.706 billion for 2024, which indicates 8.9% year-over-year growth.

UHSNegative Net Change ISRGPositive Net Change CNCNegative Net Change ZBHNegative Net Change

Zacks Equity Research

The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic

Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.

MSPositive Net Change TPositive Net Change PGPositive Net Change LLYNegative Net Change MDTNegative Net Change

Zacks Equity Research

The Zacks Analyst Blog Highlights DIA, XLF, IYY and UnitedHealth

DIA, XLF, IYY and UnitedHealth are part of the Zacks top Analyst Blog.

UNHNegative Net Change XLFPositive Net Change DIANo Net Change IYYNegative Net Change

Zacks Equity Research

Masimo (MASI) Q4 Earnings Beat Estimates, Margins Decline

Despite strength in the Hearables category, Masimo's (MASI) overall fourth-quarter results reflect soft performances.

CAHPositive Net Change MASINegative Net Change CORNegative Net Change ELVNegative Net Change

Zacks Equity Research

Zacks.com featured highlights include ICU Medical and Ardmore Shipping

ICU Medical and Ardmore Shipping are part of the Zacks Screen of the Week article.

ICUIPositive Net Change ASCNegative Net Change

Zacks Equity Research

OPKO Health's (OPK) Q4 Earnings Match Estimates, Revenues Top

Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall fourth-quarter results reflect soft performances.

CAHPositive Net Change CORNegative Net Change OPKNegative Net Change ELVNegative Net Change

Zacks Equity Research

Insulet (PODD) Q4 Earnings, Revenues Top Mark, Margins Expand

In the fourth quarter, Insulet (PODD) achieves the milestone of 425,000 estimated active global customers using Omnipod products.

SYKNegative Net Change CAHPositive Net Change CORNegative Net Change PODDNegative Net Change

Zacks Equity Research

Is a Surprise Coming for argenx (ARGX) This Earnings Season?

argenx (ARGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ARGXNegative Net Change

Zacks Equity Research

Is a Surprise Coming for Arvinas (ARVN) This Earnings Season?

Arvinas (ARVN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ARVNNegative Net Change

Zacks Equity Research

Company News for Feb 28, 2024

Companies In The Article Are: HES, CVX, M,VKTX and UNH

CVXPositive Net Change UNHNegative Net Change MNegative Net Change HESPositive Net Change VKTXPositive Net Change

Zacks Equity Research

Stock Market News for Feb 28, 2024

Wall Street closed with a mixed performance on Tuesday as investors awaited crucial inflation data, which could influence the Federal Reserve's interest rate decisions.

LOWPositive Net Change AZOPositive Net Change EYENegative Net Change

Zacks Equity Research

Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up

Denali (DNLI) reports lower than expected fourth-quarter financial results. The stock, however, rises 38% on news of funding raised by the company, which is expected to strengthen its cash position.

SNYNegative Net Change BIIBNegative Net Change PBYIPositive Net Change DNLINegative Net Change

Zacks Equity Research

Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down

Myriad Genetics (MYGN) registers a strong testing volume improvement across all its businesses in the fourth quarter of 2023.

SYKNegative Net Change CAHPositive Net Change MYGNNegative Net Change CORNegative Net Change

Zacks Equity Research

Esperion (ESPR) Q4 Earnings Top, Stock Up on Strong Revenues

Esperion's (ESPR) fourth-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.

PBYIPositive Net Change ESPRNegative Net Change

Zacks Equity Research

Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges

Ligand Pharmaceuticals (LGND) reports encouraging fourth-quarter results as earnings and sales beat estimates. Management reiterates the 2024 financial outlook.

MRKNegative Net Change LGNDNegative Net Change ALDXNegative Net Change VRNANegative Net Change

Zacks Equity Research

Alcon (ALC) Q4 Earnings Beat Estimates, Margins Expand

Alcon (ALC) delivers impressive performance across its franchises in the fourth quarter of 2023.

SYKNegative Net Change CAHPositive Net Change ALCPositive Net Change CORNegative Net Change

Zacks Equity Research

New Strong Sell Stocks for February 28th

AGL, BELFB and DRVN have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2023.

AGLNegative Net Change BELFBNegative Net Change DRVNNegative Net Change

Benjamin Rains

How to Find Top-Ranked Stocks to Buy in March

Exploring how investors can use the Filtered Zacks Rank 5 Stock Screen to help find potentially winning stocks to buy in March and throughout what looks set to be a strong 2024.

CAHPositive Net Change